Company intelligence / Profile preview

Mid Atlantic Retina

Bala Cynwyd, Pennsylvania, United States

Ownership: Private
Employees: ~354
Development stage: Other

Overview

Mid Atlantic Retina is a leading, active provider of specialized retinal care, delivering both clinical services and participating in ophthalmology research and trials, with national recognition and clinical results for therapies in macular degeneration, diabetic retinopathy, and surgical retinal interventions

Therapeutic areas: Ophthalmology
Modalities: Device (diagnostics)Biologic (intravitreal injections, surgical therapies)Small molecule (drug therapies used for retinal diseases)
Industry: Academic Hospital/University/Research

Partnerships

Wills Eye Hospital (principal faculty, research collaboration)Retina Consultants of America (clinical research and care partnership in Maryland and Pennsylvania)

Beyond the preview

Go deeper on Mid Atlantic Retina.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mid Atlantic Retina.

Explore the full profile